Abstract
CARDIAC RESYNCHRONIZATION THERAPY DOES NOT BENEFIT HEART FAILURE PATIENTS WITH ATRIAL FIBRILLATION WITHOUT ATRIO-VENTRICULAR JUNCTION ABLATION: A META-ANALYSIS
Journal of the American College of Cardiology, Vol.71(11), pp.A439-A439
03/10/2018
DOI: 10.1016/S0735-1097(18)30980-X
Abstract
Outcomes were all-cause and cardiovascular mortality, left ventricular ejection fraction (LVEF), New York heart association (NYHA) class and 6 minute walk distance (6MWD). Random effect model was used to calculate odds ratios (ORs) and 95% confidence intervals.
Details
- Title: Subtitle
- CARDIAC RESYNCHRONIZATION THERAPY DOES NOT BENEFIT HEART FAILURE PATIENTS WITH ATRIAL FIBRILLATION WITHOUT ATRIO-VENTRICULAR JUNCTION ABLATION: A META-ANALYSIS
- Creators
- Jessica Atkins - Louisiana State University Health Sciences Center ShreveportUsman Mustafa - Louisiana State University Health Sciences Center ShreveportDesiree Dawson - Louisiana State University Health Sciences Center ShreveportPratap Reddy - Louisiana State University Health Sciences Center ShreveportPaari Dominic - Louisiana State University Health Sciences Center Shreveport
- Resource Type
- Abstract
- Publication Details
- Journal of the American College of Cardiology, Vol.71(11), pp.A439-A439
- DOI
- 10.1016/S0735-1097(18)30980-X
- ISSN
- 0735-1097
- eISSN
- 1558-3597
- Publisher
- Elsevier Limited
- Language
- English
- Date published
- 03/10/2018
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984366271202771
Metrics
18 Record Views